These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9331441)

  • 21. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
    Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
    Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Factors affecting the pharmacokinetics of aminoglycoside antibiotics].
    Dyderski S
    Wiad Lek; 1989 Jul 1-15; 42(13-15):919-23. PubMed ID: 2634321
    [No Abstract]   [Full Text] [Related]  

  • 24. Measurement of Skeletal Muscle Area Improves Estimation of Aminoglycoside Clearance across Body Size.
    Crass RL; Ross BE; Derstine BA; Lichty M; Sullivan JA; Su GL; Wang SC; Pai MP
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients.
    Townsend PL; Fink MP; Stein KL; Murphy SG
    Crit Care Med; 1989 Feb; 17(2):154-7. PubMed ID: 2914447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of aminoglycoside antibiotic gentamycin in extremely premature infants--administration schedule and suggested dosage based on pharmacokinetic studies in plasma].
    Slŭncheva B; Emilova Z; Vakrilova L; Pramatarova T; Popivanova A; Svinarov D
    Akush Ginekol (Sofiia); 2006; 45(3):30-3. PubMed ID: 16889185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit.
    Ohler KH; Menke JA; Fuller L
    Am J Perinatol; 2000; 17(6):285-90. PubMed ID: 11144309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of tobramycin and gentamicin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.
    Spencer H; Kozlowska W; Davies JC; Webber P; Chadwick M; Kerr J; Makhecha S
    J Cyst Fibros; 2005 Sep; 4(3):209. PubMed ID: 15994133
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycoside pharmacokinetics in Alaskan natives.
    McAndrews KL; Murphy JE
    Am J Health Syst Pharm; 1995 Sep; 52(18):2015-8. PubMed ID: 8528870
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of aminoglycoside clearance and calculated serum creatinine clearances.
    Deeter RG; Krauss EA; Penn F; Nahaczewski AE
    Ther Drug Monit; 1989; 11(2):155-61. PubMed ID: 2718220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External validation of aminoglycoside models used in web calculators and clinical decision support systems after laboratory conversion to serum creatinine isotope dilution mass spectrometry assay.
    Wolowich WR; Steinberg JG
    Clin Ther; 2012 Apr; 34(4):803-10. PubMed ID: 22421578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.
    Huang V; Rybak MJ
    Antimicrob Agents Chemother; 2005 Jan; 49(1):302-8. PubMed ID: 15616309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability in pharmacokinetic values for gentamicin, tobramycin, and netilmicin in patients with renal insufficiency.
    Matzke GR; Millikin SP; Kovarik JM
    Clin Pharm; 1989 Nov; 8(11):800-6. PubMed ID: 2805631
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of small-for-gestational age (SGA) status on gentamicin pharmacokinetics in neonates.
    Lulic-Botica M; Sheer T; Edwards D; Thomas RL; Natarajan G
    J Clin Pharmacol; 2014 Jan; 54(1):39-45. PubMed ID: 24122736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of tobramycin pharmacokinetics in burn patients to evaluate the potential utility of once-daily dosing in this population.
    Vella D; Walker SA; Walker SE; Daneman N; Simor A
    J Burn Care Res; 2014; 35(4):e240-9. PubMed ID: 24043237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of gentamicin in South African newborns.
    Botha JH; du Preez MJ; Adhikari M
    Eur J Clin Pharmacol; 2003 Dec; 59(10):755-9. PubMed ID: 14566440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.